Candidemia in Patients with Ventricular Assist Devices
Author(s) -
Shmuel Shoham,
Robyn K. Shaffer,
L. Sweet,
Roger Cooke,
Nancy Donegan,
Steven W. Boyce
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/509640
Subject(s) - medicine , candida parapsilosis , candida albicans , ventricular assist device , fungemia , mortality rate , intensive care medicine , mycosis , surgery , antifungal , microbiology and biotechnology , dermatology , heart failure , biology
During the period 1998-2004, candidemia developed in 7 of 117 ventricular assist device recipients at our hospital, and the associated mortality rate was 71%. Five cases of candidemia were due to Candida parapsilosis, and 2 were due to Candida albicans. Three of the 7 patients with ventricular assist device-associated Candida bloodstream infections were cured, and the device was retained in 2 of the 3 patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom